Clinical Trial Update: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response [NA]

View source ↗

Summary

A terminated clinical trial (NCT02439008) investigating early biomarkers of tumor response to high-dose hypofractionated radiotherapy across hepatocellular carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Hepatocellular Carcinoma
• Kidney Cancer
• Melanoma

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Carcinoma, Hepatocellular, Colorectal Neoplasms | NA | Status: TERMINATED